Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.

The European Medicines Agency (EMA) has approved Moleculin Biotech’s clinical trial application (CTA) for a pivotal, ...

Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...

Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...

A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines ...

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an ...

The medicine will remain on the shelves but will come with additional warnings about the side effects, which appear to be ...

The PDCO’s positive opinion is based on PolTREG’s original preTreg clinical trial protocol initiated in October 2024, which enrolled children aged 6–16 years in Stage 1 type 1 diabetes. In its ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...